Global and China Human Coagulation Factor VIII Sales Market Report to 2020
- QYR632473
- 123 Pages
- July 2016
- Pharmaceuticals
Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering
Recombinant Factor VIII
Plasma-derived Factor VIII
Type 3
Split by manufacturers, this report focuses on the production, price of each type, average price of Human Coagulation Factor VIII, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Baxter
Bayer
Pfizer
CSL Behring
Grifols
Octapharma
BPL
Kedrion
Split by applications, this report focuses on consumption and growth rate of Human Coagulation Factor VIII in each application, can be divided into
Hemophilia A
Spontanous + Traum
Surgical
Other
Split by regions, this report focuses on the production, revenue, consumption and market share of Human Coagulation Factor VIII in these regions, from 2011 to 2020 (forecast), covering
China
USA
EU
Japan
India
Southeast Asia
Global and China Human Coagulation Factor VIII Research Report to 2020
1 Human Coagulation Factor VIII Overview and Price of Each Type
1.1 Product Overview and Scope of Human Coagulation Factor VIII
1.2 Global and China Human Coagulation Factor VIII Production, Growth Rate 2011 to 2020
1.3 Global and China Human Coagulation Factor VIII Revenue, Growth Rate 2011 to 2020
1.4 Product Segments and Price of Each Type
1.4.1 Recombinant Factor VIII and Price List (2015-2016)
1.4.2 Plasma-derived Factor VIII and Price List (2015-2016)
1.4.3 Type 3 and Price List (2015-2016)
1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.5.1 Price List (Interviewed) of Recombinant Factor VIII by Key Manufacturers
1.5.2 Price List (Interviewed) of Plasma-derived Factor VIII by Key Manufacturers
1.5.3 Price List (Interviewed) of Type 3 by Key Manufacturers
1.6 Global and China Human Coagulation Factor VIII Market Share by Type in 2015
1.6.1 Global Human Coagulation Factor VIII Market Share by Type in 2015
1.6.2 China Human Coagulation Factor VIII Market Share by Type in 2015
2 Global and China Market Competition Analysis by Manufacturers
2.1 Global Market Human Coagulation Factor VIII Production, Revenue and Share List of Key Manufacturers 2015 to 2016
2.1.1 Global Market Human Coagulation Factor VIII Production and Share of Key Manufacturers 2015 to 2016
2.1.2 Global Market Human Coagulation Factor VIII Revenue and Share of Key Manufacturers 2015 to 2016
2.1.3 Global Market Human Coagulation Factor VIII Average Price of Key Manufacturers 2015 to 2016
2.2 China Market Human Coagulation Factor VIII Production, Revenue and Share of Key Manufacturers 2015 to 2016
2.2.1 China Market Human Coagulation Factor VIII Production and Share of Key Manufacturers 2015 to 2016
2.2.2 China Market Human Coagulation Factor VIII Revenue and Share of Key Manufacturers 2015 to 2016
2.3 Global Human Coagulation Factor VIII Manufacturing Base Distribution and Product Type of each Manufacturer
3 Global and China Human Coagulation Factor VIII Production, Revenue and Growth Rate by Type
3.1 Global Human Coagulation Factor VIII Production, Revenue and Growth Rate by Type (2011-2020)
3.1.1 Global Human Coagulation Factor VIII Production and Market Share by Type (2011-2020)
3.1.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2020)
3.1.3 Global Human Coagulation Factor VIII Price by Type (2011-2020)
3.2 Global Human Coagulation Factor VIII Production Growth Rate by Type (2011-2020)
3.2.1 Recombinant Factor VIII Production and Production Growth Rate 2011-2020
3.2.2 Plasma-derived Factor VIII Production and Production Growth Rate 2011-2020
3.2.3 Type 3 Production and Production Growth Rate 2011-2020
3.3 China Human Coagulation Factor VIII Production, Revenue and Growth Rate by Type (2011-2020)
3.3.1 China Human Coagulation Factor VIII Production and Market Share by Type (2011-2020)
3.3.2 China Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2020)
3.3.3 China Human Coagulation Factor VIII Price by Type (2011-2020)
3.4 China Human Coagulation Factor VIII Production Growth Rate by Type (2011-2020)
3.4.1 Recombinant Factor VIII Production and Production Growth Rate 2011-2020
3.4.2 Plasma-derived Factor VIII Production and Production Growth Rate 2011-2020
3.4.3 Type 3 Production and Production Growth Rate 2011-2020
4 Global and China Human Coagulation Factor VIII Key Manufacturers Analysis
4.1 Baxter
4.1.1 Company Basic Information, Manufacturing Base and Competitors
4.1.2 Human Coagulation Factor VIII Product Segment of Baxter by Type
4.1.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of Baxter
4.1.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of Baxter
4.1.2.3 Type 3 and Price in 2015 and 2016 of Baxter
4.1.3 Human Coagulation Factor VIII Production, Revenue, Price of Baxter 2015 to 2016
4.1.4 Interviewee, Name and Contact
4.2 Bayer
4.2.1 Company Basic Information, Manufacturing Base and Competitors
4.2.2 Human Coagulation Factor VIII Product Segment of Bayer by Type
4.2.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of Bayer
4.2.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of Bayer
4.2.2.3 Type 3 and Price in 2015 and 2016 of Bayer
4.2.3 Human Coagulation Factor VIII Production, Revenue, Price of Bayer 2015 to 2016
4.2.4 Interviewee, Name and Contact
4.3 Pfizer
4.3.1 Company Basic Information, Manufacturing Base and Competitors
4.3.2 Human Coagulation Factor VIII Product Segment of Pfizer by Type
4.3.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of Pfizer
4.3.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of Pfizer
4.3.2.3 Type 3 and Price in 2015 and 2016 of Pfizer
4.3.3 Human Coagulation Factor VIII Production, Revenue, Price of Pfizer 2015 to 2016
4.3.4 Interviewee, Name and Contact
4.4 CSL Behring
4.4.1 Company Basic Information, Manufacturing Base and Competitors
4.4.2 Human Coagulation Factor VIII Product Segment of CSL Behring by Type
4.4.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of CSL Behring
4.4.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of CSL Behring
4.4.2.3 Type 3 and Price in 2015 and 2016 of CSL Behring
4.4.3 Human Coagulation Factor VIII Production, Revenue, Price of CSL Behring 2015 to 2016
4.4.4 Interviewee, Name and Contact
4.5 Grifols
4.5.1 Company Basic Information, Manufacturing Base and Competitors
4.5.2 Human Coagulation Factor VIII Product Segment of Grifols by Type
4.5.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of Grifols
4.5.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of Grifols
4.5.2.3 Type 3 and Price in 2015 and 2016 of Grifols
4.5.3 Human Coagulation Factor VIII Production, Revenue, Price of Grifols 2015 to 2016
4.5.4 Interviewee, Name and Contact
4.6 Octapharma
4.6.1 Company Basic Information, Manufacturing Base and Competitors
4.6.2 Human Coagulation Factor VIII Product Segment of Octapharma by Type
4.6.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of Octapharma
4.6.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of Octapharma
4.6.2.3 Type 3 and Price in 2015 and 2016 of Octapharma
4.6.3 Human Coagulation Factor VIII Production, Revenue, Price of Octapharma 2015 to 2016
4.6.4 Interviewee, Name and Contact
4.7 BPL
4.7.1 Company Basic Information, Manufacturing Base and Competitors
4.7.2 Human Coagulation Factor VIII Product Segment of BPL by Type
4.7.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of BPL
4.7.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of BPL
4.7.2.3 Type 3 and Price in 2015 and 2016 of BPL
4.7.3 Human Coagulation Factor VIII Production, Revenue, Price of BPL 2015 to 2016
4.7.4 Interviewee, Name and Contact
4.8 Kedrion
4.8.1 Company Basic Information, Manufacturing Base and Competitors
4.8.2 Human Coagulation Factor VIII Product Segment of Kedrion by Type
4.8.2.1 Recombinant Factor VIII and Price in 2015 and 2016 of Kedrion
4.8.2.2 Plasma-derived Factor VIII and Price in 2015 and 2016 of Kedrion
4.8.2.3 Type 3 and Price in 2015 and 2016 of Kedrion
4.8.3 Human Coagulation Factor VIII Production, Revenue, Price of Kedrion 2015 to 2016
4.8.4 Interviewee, Name and Contact
5 Global Human Coagulation Factor VIII Production by Regions 2011-2020
5.1 Global Human Coagulation Factor VIII Production and Revenue by Regions 2011-2020
5.1.1 Global Human Coagulation Factor VIII Production by Regions 2011-2020
5.1.2 Global Human Coagulation Factor VIII Revenue by Regions 2011-2020
5.2 China Human Coagulation Factor VIII Production and Revenue Growth Rate 2011-2020
5.3 USA Human Coagulation Factor VIII Production and Revenue Growth Rate 2011-2020
5.4 EU Human Coagulation Factor VIII Production and Revenue Growth Rate 2011-2020
5.5 Japan Human Coagulation Factor VIII Production and Revenue Growth Rate 2011-2020
5.6 Southeast Asia Human Coagulation Factor VIII Production and Revenue Growth Rate 2011-2020
5.7 India Human Coagulation Factor VIII Production and Revenue Growth Rate 2011-2020
6 Global Human Coagulation Factor VIII Consumption by Regions 2011-2020
6.1 Global Human Coagulation Factor VIII Consumption by Regions 2011-2020
6.2 China Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
6.3 USA Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
6.4 EU Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
6.5 Japan Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
6.6 Southeast Asia Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
6.7 India Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
7 Global Human Coagulation Factor VIII Analysis by Application and Client (Buyers)
7.1 Global Human Coagulation Factor VIII Consumption and Market Share by Application 2011-2020
7.2 Hemophilia A
7.2.1 Hemophilia A Analysis
7.2.2 Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Hemophilia A
7.3 Spontanous + Traum
7.3.1 Spontanous + Traum Analysis
7.3.2 Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Spontanous + Traum
7.4 Surgical
7.4.1 Surgical Analysis
7.4.2 Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Surgical
7.5 Other
7.5.1 Other Analysis
7.5.2 Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Other
8 Human Coagulation Factor VIII Technology and Development Trend
8.1 Human Coagulation Factor VIII Technology Analysis
8.1.1 Global Human Coagulation Factor VIII Technology
8.1.2 China Human Coagulation Factor VIII Technology
8.2 Human Coagulation Factor VIII Technology Development Trend Analysis
8.2.1 Global Human Coagulation Factor VIII Technology Development Trend
8.2.2 China Human Coagulation Factor VIII Technology Development Trend
9 Research Findings and Conclusion
Figure Picture of Human Coagulation Factor VIII
Figure Global Human Coagulation Factor VIII Production and Growth Rate 2011 to 2020
Figure China Human Coagulation Factor VIII Production and Growth Rate 2011 to 2020
Figure Global Human Coagulation Factor VIII Revenue and Growth Rate 2011 to 2020
Figure China Human Coagulation Factor VIII Revenue and Growth Rate 2011 to 2020
Figure Picture of Recombinant Factor VIII
Figure Picture of Plasma-derived Factor VIII
Figure Picture of Type 3
Table Price List (Interviewed) of Recombinant Factor VIII by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Plasma-derived Factor VIII by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Type 3 by Key Manufacturers in 2015 and 2016
Figure Global Human Coagulation Factor VIII Market Share by Type in 2015
Figure China Human Coagulation Factor VIII Market Share by Type in 2015
Table Global Market Human Coagulation Factor VIII Production of Key Manufacturers 2015 to 2016
Table Global Market Human Coagulation Factor VIII Production Share of Key Manufacturers 2015 to 2016
Table Global Market Human Coagulation Factor VIII Revenue of Key Manufacturers 2015 to 2016
Table Global Market Human Coagulation Factor VIII Revenue Share of Key Manufacturers 2015 to 2016
Table Global Market Human Coagulation Factor VIII Average Price of Key Manufacturers 2015 to 2016
Table China Market Human Coagulation Factor VIII Production of Key Manufacturers 2015 to 2016
Table China Market Human Coagulation Factor VIII Production Share of Key Manufacturers 2015 to 2016
Table China Market Human Coagulation Factor VIII Revenue of Key Manufacturers 2015 to 2016
Table China Market Human Coagulation Factor VIII Revenue Share of Key Manufacturers 2015 to 2016
Table Global Human Coagulation Factor VIII Manufacturing Base Distribution and Product Type of each Manufacturer
Table Global Human Coagulation Factor VIII Production by Type (2011-2020)
Table Global Human Coagulation Factor VIII Production Market Share by Type (2011-2020)
Table Global Human Coagulation Factor VIII Revenue by Type (2011-2020)
Table Global Human Coagulation Factor VIII Revenue Market Share by Type (2011-2020)
Figure Global Human Coagulation Factor VIII Price by Type (2011-2020)
Figure Recombinant Factor VIII Production and Production Growth Rate 2011-2020
Figure Plasma-derived Factor VIII Production and Production Growth Rate 2011-2020
Figure Type 3 Production and Production Growth Rate 2011-2020
Table China Human Coagulation Factor VIII Production by Type (2011-2020)
Table China Human Coagulation Factor VIII Production Market Share by Type (2011-2020)
Table China Human Coagulation Factor VIII Revenue by Type (2011-2020)
Table China Human Coagulation Factor VIII Revenue Market Share by Type (2011-2020)
Figure China Human Coagulation Factor VIII Price by Type (2011-2020)
Figure Recombinant Factor VIII Production and Production Growth Rate 2011-2020
Figure Plasma-derived Factor VIII Production and Production Growth Rate 2011-2020
Figure Type 3 Production and Production Growth Rate 2011-2020
Table Baxter Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of Baxter
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of Baxter
Table Type 3 and Price in 2015 and 2016 of Baxter
Table Human Coagulation Factor VIII Production, Revenue, Price of Baxter 2015 to 2016
Table Bayer Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of Bayer
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of Bayer
Table Type 3 and Price in 2015 and 2016 of Bayer
Table Human Coagulation Factor VIII Production, Revenue, Price of Bayer 2015 to 2016
Table Pfizer Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of Pfizer
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of Pfizer
Table Type 3 and Price in 2015 and 2016 of Pfizer
Table Human Coagulation Factor VIII Production, Revenue, Price of Pfizer 2015 to 2016
Table CSL Behring Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of CSL Behring
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of CSL Behring
Table Type 3 and Price in 2015 and 2016 of CSL Behring
Table Human Coagulation Factor VIII Production, Revenue, Price of CSL Behring 2015 to 2016
Table Grifols Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of Grifols
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of Grifols
Table Type 3 and Price in 2015 and 2016 of Grifols
Table Human Coagulation Factor VIII Production, Revenue, Price of Grifols 2015 to 2016
Table Octapharma Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of Octapharma
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of Octapharma
Table Type 3 and Price in 2015 and 2016 of Octapharma
Table Human Coagulation Factor VIII Production, Revenue, Price of Octapharma 2015 to 2016
Table BPL Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of BPL
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of BPL
Table Type 3 and Price in 2015 and 2016 of BPL
Table Human Coagulation Factor VIII Production, Revenue, Price of BPL 2015 to 2016
Table Kedrion Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of Kedrion
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of Kedrion
Table Type 3 and Price in 2015 and 2016 of Kedrion
Table Human Coagulation Factor VIII Production, Revenue, Price of Kedrion 2015 to 2016
Table Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of
Table Type 3 and Price in 2015 and 2016 of
Table Human Coagulation Factor VIII Production, Revenue, Price of 2015 to 2016
Table Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of
Table Type 3 and Price in 2015 and 2016 of
Table Human Coagulation Factor VIII Production, Revenue, Price of 2015 to 2016
Table Basic Information List
Table Recombinant Factor VIII and Price in 2015 and 2016 of
Table Plasma-derived Factor VIII and Price in 2015 and 2016 of
Table Type 3 and Price in 2015 and 2016 of
Table Human Coagulation Factor VIII Production, Revenue, Price of 2015 to 2016
Table Global Human Coagulation Factor VIII Production by Regions 2011-2020
Table Global Human Coagulation Factor VIII Production Share by Regions 2011-2020
Table Global Human Coagulation Factor VIII Revenue by Regions 2011-2020
Table Global Human Coagulation Factor VIII Revenue Share by Regions 2011-2020
Figure China Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure China Human Coagulation Factor VIII Revenue Growth Rate 2011-2020
Figure USA Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure USA Human Coagulation Factor VIII Revenue Growth Rate 2011-2020
Figure EU Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure EU Human Coagulation Factor VIII Revenue Growth Rate 2011-2020
Figure Japan Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure Japan Human Coagulation Factor VIII Revenue Growth Rate 2011-2020
Figure Southeast Asia Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure Southeast Asia Human Coagulation Factor VIII Revenue Growth Rate 2011-2020
Figure India Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure India Human Coagulation Factor VIII Revenue Growth Rate 2011-2020
Table Global Human Coagulation Factor VIII Consumption by Regions 2011-2020
Table Global Human Coagulation Factor VIII Consumption Share by Regions 2011-2020
Figure China Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
Figure USA Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
Figure EU Human Coagulation Factor VIII Production Growth Rate 2011-2020
Figure Japan Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
Figure Southeast Asia Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
Figure India Human Coagulation Factor VIII Consumption Growth Rate 2011-2020
Table Global Human Coagulation Factor VIII Consumption by Application 2011-2020
Table Global Human Coagulation Factor VIII Consumption Market Share by Application 2011-2020
Figure Hemophilia A Human Coagulation Factor VIII Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Hemophilia A
Figure Spontanous + Traum Human Coagulation Factor VIII Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Spontanous + Traum
Figure Surgical Human Coagulation Factor VIII Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Surgical
Figure Other Human Coagulation Factor VIII Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Human Coagulation Factor VIII in Other
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
